With scope unknown, nursing homes brace for new schizophrenia audits
By
Kimberly Marselas
Feb 10, 2023
Three weeks after federal officials announced they would begin auditing nursing homes for overuse of schizophrenia diagnoses, providers are still looking for answers about what those investigations will...
Group re-assessing antipsychotic label warning
By
Kristen Fischer
Mar 22, 2024
Project PAUSE (Psychoactive Appropriate Use for Safety and Effectiveness) will hold a workshop exploring black box warnings on antipsychotic medication instructions, especially for older adults.
Reducing antipsychotics one resident at a time
By
John O'Connor
Dec 02, 2013
Like many bad habits, the overuse of antipsychotics is not going down without a fight. Still, there are reasons for long-term optimism.
Successfully decreasing antipsychotics use
By
Elizabeth Newman
May 01, 2012
If you’re wondering if anyone outside the profession is paying attention to the antipsychotics-use debate in long-term care, allow me to direct your attention to Boston.
Sorting out the antipsychotic quality measures
By
Steven Littlehale
Mar 05, 2013
While antipsychotic measurements can vary, providers must carefully and thoroughly examine all antipsychotic medication use in their facility.
The importance of informed consent in antipsychotic regulations
By
Karen Robson
Mar 16, 2022
Informed consent is not consistently interpreted in regards to the use of drugs such as antipsychotics in nursing home residents with dementia.